ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	11/196	30/7206	1.58513170359e-10
ko04060	Cytokine-cytokine receptor interaction	23/196	191/7206	1.45334542265e-09
ko04380	Osteoclast differentiation	18/196	134/7206	1.75504065051e-08
ko05152	Tuberculosis	20/196	187/7206	1.37484054456e-07
ko04612	Antigen processing and presentation	12/196	77/7206	9.13878451599e-07
ko04660	T cell receptor signaling pathway	15/196	124/7206	1.1376423097e-06
ko04145	Phagosome	17/196	162/7206	1.64058809539e-06
ko04650	Natural killer cell mediated cytotoxicity	13/196	97/7206	1.87901983024e-06
ko04062	Chemokine signaling pathway	19/196	201/7206	1.940252745e-06
ko05164	Influenza A	17/196	167/7206	2.50697108489e-06
ko04620	Toll-like receptor signaling pathway	13/196	100/7206	2.66835715684e-06
ko05162	Measles	14/196	120/7206	4.05255613351e-06
ko05150	Staphylococcus aureus infection	8/196	36/7206	4.08583076155e-06
ko05140	Leishmaniasis	11/196	75/7206	4.87106928144e-06
ko04621	NOD-like receptor signaling pathway	16/196	157/7206	4.93882547505e-06
ko04670	Leukocyte transendothelial migration	15/196	151/7206	1.34771132607e-05
ko05144	Malaria	8/196	45/7206	2.35896846699e-05
ko04666	Fc gamma R-mediated phagocytosis	13/196	122/7206	2.43801711692e-05
ko05168	Herpes simplex infection	16/196	182/7206	3.22891255366e-05
ko05330	Allograft rejection	6/196	24/7206	3.35335557215e-05
ko05145	Toxoplasmosis	13/196	126/7206	3.44505218843e-05
ko04672	Intestinal immune network for IgA production	7/196	37/7206	5.09549190121e-05
ko05320	Autoimmune thyroid disease	6/196	29/7206	0.000105648830422
ko05321	Inflammatory bowel disease (IBD)	8/196	56/7206	0.000120322651689
ko04658	Th1 and Th2 cell differentiation	10/196	96/7206	0.000259951425061
ko05133	Pertussis	9/196	87/7206	0.000556210232702
ko04217	Necroptosis	13/196	178/7206	0.00108000682435
ko04664	Fc epsilon RI signaling pathway	8/196	77/7206	0.00109507635076
ko04064	NF-kappa B signaling pathway	9/196	96/7206	0.00113954535022
ko05332	Graft-versus-host disease	4/196	18/7206	0.00120386836739
ko04610	Complement and coagulation cascades	8/196	79/7206	0.00129635741529
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/196	191/7206	0.00204600330754
ko04659	Th17 cell differentiation	9/196	106/7206	0.00228645470894
ko05161	Hepatitis B	12/196	173/7206	0.00258219593985
ko04142	Lysosome	11/196	151/7206	0.00264450030297
ko04514	Cell adhesion molecules (CAMs)	10/196	130/7206	0.00276307524921
ko05323	Rheumatoid arthritis	8/196	89/7206	0.00278600665378
ko04630	Jak-STAT signaling pathway	10/196	132/7206	0.00308862730514
ko04622	RIG-I-like receptor signaling pathway	6/196	62/7206	0.00650543836337
ko05142	Chagas disease (American trypanosomiasis)	9/196	130/7206	0.00878531998963
ko04662	B cell receptor signaling pathway	7/196	88/7206	0.00979926865321
ko05310	Asthma	3/196	17/7206	0.0101697683068
ko04940	Type I diabetes mellitus	4/196	32/7206	0.0105168952204
ko04020	Calcium signaling pathway	1/196	265/7206	0.0106759889238
ko03050	Proteasome	5/196	54/7206	0.0152116499935
ko00120	Primary bile acid biosynthesis	3/196	20/7206	0.0160613106984
ko05416	Viral myocarditis	5/196	55/7206	0.0163740412521
ko05020	Prion diseases	4/196	40/7206	0.0226013643074
ko05034	Alcoholism	1/196	238/7206	0.0227298643018
ko04640	Hematopoietic cell lineage	5/196	64/7206	0.0295488612646
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/196	135/7206	0.0305142850728
ko04210	Apoptosis	10/196	180/7206	0.0312659085471
ko05016	Huntington's disease	1/196	215/7206	0.0315756507094
ko05160	Hepatitis C	9/196	153/7206	0.0374505430012
ko04611	Platelet activation	9/196	163/7206	0.043988693854
ko04080	Neuroactive ligand-receptor interaction	5/196	423/7206	0.0440527799049